Kryo completed the merger with KKR-backed Ebb Therapeutics.

Kryo, an innovator of temperature-regulated and climate-control sleep solutions, completed the merger with KKR-backed Ebb Therapeutics, a sleep tech company. Financial terms were not disclosed. Additionally, KKR invested $37m in the combined company. "This combination is validation that the world is ready to take a fresh look at sleep and incorporate clinically researched solutions into everyday life. This investment and our merger with Ebb will help to accelerate growth into new spaces for consumers, meeting them where they are in the journey, with solutions for the bedroom, and on-the-go resources to help coach them along the way,” Tara Youngblood, Kryo CEO and Co-Founder.